AeroLeads people directory · profile
Ken Colley Email & Phone Number
Managing Partner | Fractional Chief Medical Officer (fCMO) and Head of Clinical Development
at
BioVasc, Inc.
2 work emails found
@biovasc.com
LinkedIn matched
✓ Verified Jul 2026
4 data sources
Profile completeness 100%
Current company
Role
Managing Partner | Fractional Chief Medical Officer (fCMO) and Head of Clinical Development
Location
San Francisco, California, United States
Company size
Who is Ken Colley? Overview
A concise factual answer block for searchers comparing this professional profile.
Quick answer
Ken Colley is listed as Managing Partner | Fractional Chief Medical Officer (fCMO) and Head of Clinical Development at BioVasc, Inc., a with 2 employees, based in San Francisco, California, United States. AeroLeads shows a work email signal at biovasc.com and a matched LinkedIn profile for Ken Colley.
Ken Colley previously worked as Managing Partner/Head of Clinical Development at Biovasc, Inc. and Clinical Development – Consultant | Contract Medical Director at Mycomedica Life Sciences, Pbc. Ken Colley holds B.S., Biological Sciences from Stanford University.
Company email context
Email format at BioVasc, Inc.
This section adds company-level context without repeating Ken Colley's masked contact details.
{first}@biovasc.com
92% confidence
AeroLeads found 2 current-domain work email signals for Ken Colley. Compare company email patterns before reaching out.
Profile bio
About Ken Colley
I am in the business of developing meaningful clinical data.Experienced MD/PhD physician-scientist-entrepreneur developing therapeutic products, clinical breakthroughs, alliances, and new ventures in the healthcare and greater biosciences industries for for more than two decades.• BioPharma/Biotech/Medtech/Nutratech product development and translational medicine expert, successfully advancing life-changing healthcare projects forward from R&D through human proof-of-concept mid-stage clinical studies [see "Specialities" below].• Successful development experience with small and large molecule biopharma drugs, and gene and cell biotherapies, including preclinical, translational, and clinical development studies. Expertise with new therapeutic products at the opportunity-rich convergence of biotech and medtech (medical devices) at innovative young companies.• Integrative Health Practitioner, licensed physician offering regenerative medicine therapies and precision/personalized healthcare treatments.Specialties and Experience: Clinical Development / Translational Medicine / Translational Product Development neuropsychopharmacology – neurodegenerative diseases – CNS therapeutics cardiovascular medicine, vascular biology, angiogenesis, atherosclerosis, cardiometabolic risk biotechnology, pharmacology, drug development, molecular medicine regenerative medicine, tissue engineering medtech, medical devices, device-pharma interfaces, drug delivery systems highly medically-rationaled nutraceuticals venture capital business development medical & clinical affairs
Listed skills include Clinical Development, Biotechnology, Drug Development, Medical Devices, and 35 others.
Current workplace
Ken Colley's current company
Company context helps verify the profile and gives searchers a useful next step.
Biovasc, Inc.
16 roles · 39 years
Ken Colley work experience
A career timeline built from the work history available for this profile.
Managing Partner/Head Of Clinical Development
CurrentClinical Development specialist for biopharma/biotech SponsorsStartup incubator/accelerator for emerging BioPharma | Biotech | Medtech | Nutratech companies• Product development, alliances, fundraising and consulting in biomedicine and healthcare• Strong internal development and spinout program within key Life Sciences and Healthcare domainsSuccessfully completed numerous Phase 1 through advanced Phase 2 studies ★ Achieving Proof of Concept objectives in patients (huPOC), across multiple clinical indications• clinical strategy, protocol development, clinical safety surveillance and medical monitoring• data analysis, reporting, follow-up• medical contributions to CSR, presentations, peer-reviewed publications• KME/KOL interface, support in-house cross-functional teams and partnersClinical Development Consultant/Contract Medical Director with companies including MycoMedica Life Sciences (Shelton WA), XWPharma (Redwood City CA), PharmaDirections Inc (Cary NC), Theravance Biopharma (South San Francisco CA), Avanir Pharmaceuticals/ (Aliso Viejo CA) and Otsuka Pharma Co US (Princeton NJ).
Jun 2003 - Present
Clinical Development – Consultant | Contract Medical Director
CurrentClinical stage biopharmaceutical company with a mission to revolutionize the development of a new class of safe and efficacious psychedelic medications for mental health and neurodegenerative disorders.
Sep 2022 - Present
Clinical Development – Consultant | Contract Medical Director
Current
May 2023 - Present
Clinical Development – Consultant | Contract Medical Director
CurrentClinical stage biopharmaceutical company dedicated to the discovery and development of CNS therapeutics applying novel platform chemistry to time-regulated neurobiology.
Feb 2018 - Present
Clinical Development – Consultant | Contract Medical Director
May 2012 - Oct 2022
Clinical Development – Consultant | Contract Medical Director
Jan 2019 - Apr 2022
Scientific And Clinical Advisory Board
Elliptical Therapeutics, Llc
Elliptical Therapeutics is an emerging company using off-patent non-opioid, non-narcotic drugs in improved formulations and delivery modalities to treat pain. [ellipticaltherapeutics.com]
Aug 2015 - Aug 2019
Medical Director And Head Of Translational Medicine
Cyterion Inc.
Regenerative Medicine company developing gene and cell therapy medicines targeting skin and tissues damaged due to complications from diabetes.
Aug 2011 - Sep 2013
Venture Partner
Elliptical Ventures
Venture capital for emerging life science and healthcare companies.
Jan 2007 - Jun 2012
Director Of Medical Affairs
Medical Director of publically-traded company focused on the development and commercialization of proprietary cardiovascular diagnostic products and advanced cardiac biomarkers, with international distribution of the PLAC Test®.
Jun 2009 - Jul 2011
Vice President, Pharmaceutical Product Development
Responsible for pharmaceutical R&D, product development, preclinical and clinical aspects of Medlogics' cardiovascular drug+device product development. Focus on interventional cardiology and next generation DES.
Feb 2004 - Jan 2009
Director Of Science & Technology
Feb 2004 - Jun 2007
Vp Product Development
Osteogenix, Inc.
Innovative osteobiologics company developing new therapeutics for bone repair and diseases utilizing a “molecular orthopedics” platform. Acquired by Medtronic [MDT].
2005 - 2006
~1 yr
Head Of Technology, Chief Medical Officer, Founding Ceo
Angiogenix, Inc. (Burlingame Ca)
New cardiovascular therapeutics for ischemic diseases
May 1998 - Jun 2003
Project Leader
Sustained release drug delivery systems, transdermals
1988 - 1990
~2 yrs
4 education records
Ken Colley education
B.S., Biological Sciences
Stanford University
M.D. And Ph.D., Medicine And Molecular Pharmacology
Georgetown University School Of Medicine
Resident, Internal Medicine
The Johns Hopkins University School Of Medicine
Hs Diploma
William Penn Charter School
FAQ
Frequently asked questions about Ken Colley
Quick answers generated from the profile data available on this page.
What company does Ken Colley work for?
Ken Colley works for BioVasc, Inc..
What is Ken Colley's role at BioVasc, Inc.?
Ken Colley is listed as Managing Partner | Fractional Chief Medical Officer (fCMO) and Head of Clinical Development at BioVasc, Inc..
What is Ken Colley's email address?
AeroLeads has found 2 work email signals at @biovasc.com for Ken Colley at BioVasc, Inc..
Where is Ken Colley based?
Ken Colley is based in San Francisco, California, United States while working with BioVasc, Inc..
What companies has Ken Colley worked for?
Ken Colley has worked for Biovasc, Inc., Mycomedica Life Sciences, Pbc, Pharmadirections, Xwpharma, and Theravance Biopharma Us, Inc..
Who are Ken Colley's colleagues at BioVasc, Inc.?
Ken Colley's colleagues at BioVasc, Inc. include Thiago Barbosa.
How can I contact Ken Colley?
You can use AeroLeads to view verified contact signals for Ken Colley at BioVasc, Inc., including work email, phone, and LinkedIn data when available.
What schools did Ken Colley attend?
Ken Colley holds B.S., Biological Sciences from Stanford University.
What skills is Ken Colley known for?
Ken Colley is listed with skills including Clinical Development, Biotechnology, Drug Development, Medical Devices, Life Sciences, Pharmacology, Clinical Research, and Lifesciences.
Find 750M verified contacts
Search by job title, company, industry, location, and seniority. Export verified B2B contact data when you need it.
Start free trial